No connection

Search Results

BKD vs ICUI

BKD
Brookdale Senior Living Inc.
BEARISH
Price
$12.95
Market Cap
$3.08B
Sector
Healthcare
AI Confidence
85%
ICUI
ICU Medical, Inc.
BEARISH
Price
$125.68
Market Cap
$3.14B
Sector
Healthcare
AI Confidence
80%

Valuation

P/E Ratio
BKD
--
ICUI
4189.33
Forward P/E
BKD
-23.33
ICUI
13.66
P/B Ratio
BKD
-462.5
ICUI
1.46
P/S Ratio
BKD
1.0
ICUI
1.41
EV/EBITDA
BKD
18.07
ICUI
13.35

Profitability

Gross Margin
BKD
27.57%
ICUI
36.84%
Operating Margin
BKD
2.36%
ICUI
4.83%
Profit Margin
BKD
-9.95%
ICUI
0.03%
ROE
BKD
-212.27%
ICUI
0.04%
ROA
BKD
0.92%
ICUI
1.66%

Growth

Revenue Growth
BKD
4.2%
ICUI
-14.1%
Earnings Growth
BKD
--
ICUI
--

Financial Health

Debt/Equity
BKD
--
ICUI
0.63
Current Ratio
BKD
0.84
ICUI
2.39
Quick Ratio
BKD
0.5
ICUI
0.99

Dividends

Dividend Yield
BKD
--
ICUI
--
Payout Ratio
BKD
0.0%
ICUI
0.0%

AI Verdict

BKD BEARISH

The Advanced Deterministic Scorecard reveals a deeply concerning financial profile for Brookdale Senior Living (BKD), with a Piotroski F-Score of just 2/9 indicating severe weakness in fundamental health. Despite strong recent price performance (+163.2% over 1Y), the company is unprofitable (ROE: -212.27%, Profit Margin: -9.95%), carries significant liquidity risk (Current Ratio: 0.84), and has consistently missed earnings estimates—0 out of the last 4 quarters beaten, with an average surprise of -101.87%. Valuation metrics are distorted (Price/Book: -462.50, Forward P/E: -23.33) due to negative equity and earnings, while the lack of an Altman Z-Score suggests potential distress risk. Analysts rate it a 'strong_buy' but with only 4 analysts and no meaningful insider activity, the bullish sentiment lacks conviction.

Strengths
Revenue growth of 4.20% YoY shows modest top-line resilience in a challenging senior care environment
Gross margin of 27.57% indicates some operational efficiency at the core service level
Price/Sales ratio of 1.00 is reasonable relative to unprofitable peers in the healthcare sector
Risks
Piotroski F-Score of 2/9 signals extreme financial distress and poor earnings quality
Negative book value and ROE of -212.27% indicate eroding shareholder equity and likely balance sheet insolvency
Current Ratio of 0.84 and Quick Ratio of 0.50 reveal acute liquidity risk and inability to meet short-term obligations
ICUI BEARISH

ICUI presents a stark contradiction between a strong balance sheet and a collapsing income statement. While the Piotroski F-Score of 8/9 indicates exceptional structural financial health, the company is suffering from a severe earnings crisis, evidenced by a P/E ratio of 4189.33 and a -131.5% Q/Q EPS growth. The massive disconnect between the current price ($125.68) and the Graham Number ($7.62) suggests the stock is trading at a significant premium based on future recovery hopes rather than current fundamentals. With revenue declining by 14.1% and insiders selling, the strong health score is currently insufficient to offset the operational deterioration.

Strengths
Strong Piotroski F-Score (8/9) indicating high structural health
Healthy Current Ratio (2.39) showing strong short-term liquidity
Manageable Debt/Equity ratio (0.63)
Risks
Severe earnings collapse with recent Q/Q EPS growth of -131.5%
Negative revenue growth (-14.10% YoY) indicating market share loss or demand drop
Extreme valuation disconnect (Current P/E 4189.33 vs Forward P/E 13.66)

Compare Another Pair

BKD vs ICUI: Head-to-Head Comparison

This page compares Brookdale Senior Living Inc. (BKD) and ICU Medical, Inc. (ICUI) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile